Key Point from the Q &A with Dr. Mandar Kubal, Mumbai Telemedicine has become a very useful tool for clinicians to manage their patients. Given the ever changing contours of Covid19 treatment, doctors have to check daily for online resources. It would be wonderful if pharma can provide every specialty the latest developments in treating Covid19 with pre existing conditions instead of sending their unvaccinated field force to give brand reminders. Pharma should seek frontline worker status for Medical Reps and Field Managers as they are critical to maintain the drug supply chain. Treat the Field Force as an asset and protect them, instead of pushing them onto the field without vaccination. And many more insights from a clinician at the frontlines of treating Covid19 patients. Now on MedicinMan YouTube Channel - https://youtu.be/J_p3paeO_eg

1. MD - Internal
Medicine
University of
Mumbai
American
Academy of HIV
Medicine
Infectious Diseases
Society of India
Dr Mandar Kubal
Infectious Diseases Specialist
Founder Director, Infectious Diseases & Pulmonary Care Pvt Ltd
Strategic Partner - WHO STOP TB Partnership
Tell us about your journey as a medic and what are the key
challenges in infectious disease management?

2. How has Covid-19 impacted your clinical practice and how do you see
telehealth and digital therapeutics impacting doctors and patients?

3. In terms of drug information/CME what are your expectations from pharma?

4. You have been very empathetic in your approach to Medical Reps – what
changes do you wish to see in their interaction with clinicians and HCWs?

5. Digital adoption by doctors and patients – the current scenario and the way
ahead?